Andrew D. Goldberg
Director, Tarsus Pharmaceuticals, Inc.
Companies
- ACHIEVE LIFE SCIENCES, INC.Board member Apr 21, 2026 to now1
- ACHIEVE LIFE SCIENCES, INC.Chief executive officer Apr 21, 2026 to now1
- ACHIEVE LIFE SCIENCES, INC.President Apr 21, 2026 to now1
- Tarsus Pharmaceuticals, Inc.Board member Oct 15, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS19,654 shares3$1.4M at $69.64Jun 12, 2026
- ACHIEVE LIFE SCIENCES, INC. ACHV0 shares4Apr 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2026Exercised options 2,954 shares of Tarsus Pharmaceuticals, Inc.3
- Jun 13, 2025Exercised options 3,350 shares of Tarsus Pharmaceuticals, Inc.5
- Mar 7, 2025Exercised options 7,000 shares at $12.89 of Tarsus Pharmaceuticals, Inc.6
- Jun 24, 2024Exercised options 3,350 shares of Tarsus Pharmaceuticals, Inc.7
- Dec 15, 2023Bought 1,000 shares at $18.96 of Tarsus Pharmaceuticals, Inc.8
- Jun 16, 2023Exercised options 2,000 shares of Tarsus Pharmaceuticals, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 16, 2025
- 6SEC EDGARForm 4 filed Mar 11, 2025
- 7SEC EDGARForm 4 filed Jun 25, 2024
- 8SEC EDGARForm 4 filed Dec 19, 2023
- 9SEC EDGARForm 4 filed Jun 21, 2023